Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2022, 4(6); doi: 10.25236/IJFM.2022.040604.

Cardiovascular Disease Traditional Chinese and Western Medicine Combined Treatment Science and Standardized Drug System Research

Author(s)

Kaixiang Zhang, Zhixiang Zhang

Corresponding Author:
Zhixiang Zhang
Affiliation(s)

Shaanxi University of Chinese Medicine, Xianyang, China

Abstract

A combination of traditional Chinese and western medicine should be adopted to improve the prevention and treatment level of cardiovascular disease according to the condition and treatment status of patients with cardiovascular disease. At the same time, patients with cardiovascular disease should maintain emotional stability during the treatment process, pay attention to diet and appropriate exercise, and combine prevention and treatment. During treatment, different drugs should be selected according to the different conditions of patients with cardiovascular disease at different ages, and the dose of drugs should be adjusted according to the patient's condition and physical condition to play the most tremendous role.

Keywords

Traditional Chinese and western medicine, prevention and treatment of cardiovascular disease; scientific drug treatment

Cite This Paper

Kaixiang Zhang, Zhixiang Zhang. Cardiovascular Disease Traditional Chinese and Western Medicine Combined Treatment Science and Standardized Drug System Research. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 6: 21-26. https://doi.org/10.25236/IJFM.2022.040604.

References

[1] Xing Xingyun, Yang Chuanhua, Guo Weixing. Cardiovascular Disease. Taiyuan: Shanxi Science and Technology Press, Vol. 18 (2020) No. 08, p.211-215.

[2] Li Jinhui. Effective measures to prevent and treat cardiovascular disease. Chinese Journal of Health and Nutrition, Vol. 24 (2021) No. 10, p.136-138.

[3] Gu Yiting, Gu Hai. Research on the combination of traditional Chinese and western medicine in the treatment of cardiovascular disease. Traditional Chinese medicine information, Vol. 12 (2020) No. 12, p.141-145.

[4] Lei Manxue. Percutaneous nephrolithotomy perioperative nursing care. Healthy Road, Vol. 16 (2021) No. 14, p.146-149.

[5] Wang Weiguo, Wang Huiling. Rational analysis of clinical drug use for cardiovascular disease. Latest Medical Information Digest, Vol. 20 (2020) No. 16, p.45-48.